NVIDIA (NASDAQ:NVDA) Given New $1,310.00 Price Target at Evercore ISI
NVIDIA (NASDAQ:NVDA – Free Report) had its price objective upped by Evercore ISI from $1,160.00 to $1,310.00 in a research report sent to investors on...
Raymond James Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $70.00
Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective cut by Raymond James from $92.00 to $70.00 in a report published on Thursday morning, Benzinga...
Kanzhun (NASDAQ:BZ) Earns Buy Rating from Analysts at HSBC
HSBC initiated coverage on shares of Kanzhun (NASDAQ:BZ – Free Report) in a research report sent to investors on Friday, MarketBeat reports. The brokerage issued...
BioNTech’s (BNTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Friday morning, Benzinga reports. HC Wainwright...
Coherus BioSciences (NASDAQ:CHRS) Rating Reiterated by HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Coherus BioSciences (NASDAQ:CHRS – Free Report) in a research report released on Friday morning, Benzinga reports....
HC Wainwright Reaffirms “Buy” Rating for BriaCell Therapeutics (NASDAQ:BCTX)
HC Wainwright restated their buy rating on shares of BriaCell Therapeutics (NASDAQ:BCTX – Free Report) in a research note issued to investors on Friday morning,...